Indefinite Delivery Contract HHSN268201600036I

This indefinite delivery contract (IDC) was awarded by the National Heart, Lung, and Blood Institute, a civilian agency within the U.S. Department of Health and Human Services, to the Altius Institute for Biomedical Sciences, a non-profit organization. The $505 million contract, known as the Centralized Omic REsource for TOPMed (CORE), has a period of performance from September 2016 to September 2021. The purpose of the CORE contract is to provide a centralized resource for omic (genetic,...

This indefinite delivery contract, awarded by the National Heart, Lung and Blood Institute (NHLBI), a component of the Department of Health and Human Services, provides for a Centralized Omics Resource (CORE) to support the Trans-Omics for Precision Medicine (TOPMed) initiative. The multiple-award contract has a total ceiling value of $505,000,000 and a period of performance through September 2033. Cedars-Sinai Medical Center, a non-profit academic medical center, was selected as a prime...

The National Heart Lung and Blood Institute (NHLBI) awarded a $505,000,000 Indefinite Delivery Contract (IDC) to the J. Craig Venter Institute, Inc. (JCVI) to provide a Centralized Omics Resource (CORE) for the Trans-Omics for Precision Medicine (TOPMed) program. This multiple-award IDC, with a period of performance through September 2021, aims to support NHLBI's genomics research initiatives by leveraging JCVI's expertise in areas such as genomics, bioinformatics, synthetic biology, and...

The National Heart, Lung and Blood Institute awarded a single-award indefinite delivery contract to Vanderbilt University Medical Center to establish the Centralized Omics Resource for its Trans-Omics for Precision Medicine initiative. This IDV has a potential value of $500 million and a period of performance through September 2033. The purpose of the contract is to provide complex data analysis, integration, and management of large-scale genomic and health datasets to support the Trans-Omics...

The National Heart, Lung and Blood Institute awarded a single-award indefinite delivery contract to Cedars-Sinai Medical Center to establish the Centralized Omics Resource for its Trans-Omics for Precision Medicine initiative. With a potential value of $500 million, this IDV enables task orders to be placed through September 2033 for complex data analysis, integration and management of large-scale genomic and health datasets to support the initiative's goals. The originating pre-solicitation...

The National Heart, Lung and Blood Institute awarded a single-award indefinite delivery contract to Psomagen Inc., a subsidiary of Macrogen, Inc., with a potential value of $500 million. The contract supports the Trans-Omics for Precision Medicine initiative through September 2033 by providing complex data analysis, integration, and management of large-scale genomic and health datasets. Specifically, the contractor will establish and operate the Centralized Omics Resource to perform...

The National Heart, Lung and Blood Institute (NHLBI) has awarded a $500,000,000 Indefinite Delivery Contract (IDC) to Stanford University to establish the Centralized Omics Resource for the Trans-Omics for Precision Medicine (TOPMed) initiative. This single-award IDC, which runs through September 2033, tasks Stanford with providing data analysis, integration, and management services for omics and health data to support NIH's precision medicine efforts. The original pre-solicitation notice sought...

The National Heart Lung and Blood Institute (NHLBI) awarded a $505 million Indefinite Delivery Contract (IDC) to The Washington University's Office of Sponsored Research Services Division, a prominent private research institution. This multiple award IDC, titled "Centralized Omics Resource (CORE)", has a period of performance through September 2021. The contract enables the NHLBI to issue task orders for specialized scientific research and development services from Washington...

The National Heart, Lung and Blood Institute, part of the National Institutes of Health and Department of Health and Human Services, awarded a single award Indefinite Delivery Contract to New York Genome Center, Inc. doing business as Nygc. The potential value of the contract is $500 million to be ordered through September 2033. A firm fixed price delivery order for $742,360 was also awarded for RNA-Seq services to support the Trans-Omics for Precision Medicine initiative's Centralized Omics...

The National Heart, Lung and Blood Institute awarded Baylor College of Medicine a single award indefinite delivery contract with a potential value of $500 million to provide Trans-Omics for Precision Medicine Centralized Omics Resource services. Under the originating contract, Baylor College of Medicine was issued a firm fixed price delivery order valued at $14.46 million to perform Task Areas 2, 3 and 4. These task areas include omics data generation, analysis and storage in support of the...